Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLuceco Plc Regulatory News (LUCE)

Share Price Information for Luceco Plc (LUCE)

Share Price is delayed by 15 minutes
Get Live Data
272.00    1.00 (0.37%)
Bid:
271.00
Ask:
272.00
Spread: 1.00 (0.369%)
Market Cap: £400.36m
LUCE Live PriceLast checked at - London Stock Exchange

Intraday Luceco Plc Share Chart

Director/PDMR Shareholding

25 Nov 2021 16:22

RNS Number : 6470T
Luceco PLC
25 November 2021
 

LUCECO PLC (THE "COMPANY")

 

Notification of Transactions of Directors, Persons Discharging Managerial Responsibilities ("PDMRs") and persons closely associated with them

 

The following notification is made under article 19.1 and in accordance with article 19.3 of the Market Abuse Regulation ("MAR"), in relation to the transfer of shares to a Charitable Fund, The Hornby Trust, by Jonathan Hornby, Chief Executive Officer of the Company.

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

 Jonathan Hornby

 

2

Reason for the notification

a)

Position/status

 Chief Executive Officer

Initial notification/Amendment

 Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Luceco PLC

b)

LEI

213800BBFZK4W4P98U76

 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of £0.0005 each

ISIN: GB00BZC0LP49

b)

Nature of transaction

Transfer of shares to a charitable trust, The Hornby Trust

c)

Price(s) and volume(s)

 Price(s)

Volume(s)

 £0

75,000

d)

Aggregated information

- Aggregated volume

- Price

 

 N/A (single transaction)

e)

Date of the transaction

2021-11-22

f)

Place of the transaction

Outside a trading venue (XOFF)

ENDS

For further information, contact Matt Webb, Chief Financial Officer 01952 238180

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBLBDBGDDDGBU
Date   Source Headline
6th Oct 20175:41 pmRNSHolding(s) in Company
22nd Sep 201710:26 amRNSDirector/PDMR Shareholding
18th Sep 20177:00 amRNSAcquisition
11th Sep 20177:00 amRNSHalf-year Report
22nd Aug 20175:12 pmRNSDirector/PDMR Shareholding
25th Jul 20177:00 amRNSTrading Statement
24th Jul 20171:26 pmRNSDirector/PDMR Shareholding
4th Jul 201710:22 amRNSDirector/PDMR Shareholding
22nd Jun 201710:17 amRNSDirector/PDMR Shareholding
8th Jun 20175:02 pmRNSReplacement Director/PDMR Shareholding
8th Jun 20175:00 pmRNSDirector/PDMR Shareholding
30th May 201711:53 amRNSDirector/PDMR Shareholding
25th May 20175:55 pmRNSResult of AGM
25th May 20177:00 amRNSAGM Trading Update
2nd May 20173:24 pmRNSDirector/PDMR Shareholding
21st Apr 20172:00 pmRNSAnnual Report 2016 and Notice of AGM
3rd Apr 20177:00 amRNSFinal Results
6th Mar 20177:00 amRNSNotice of Results
23rd Feb 201711:35 amRNSDirector/PDMR Shareholding
2nd Feb 20177:00 amRNSTrading Statement
17th Jan 20179:07 amRNSDirector Declaration
20th Oct 20168:00 amRNSAdmission to Trading
17th Oct 201612:48 pmRNSPublication of Prospectus
17th Oct 20167:00 amRNSPricing of Initial Public Offering

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.